Alkermes plc - Ordinary Shares (ALKS): Product News News

ALKS – Announces that the FDA has accepted for review the NDA for ALKS 5461 for the adjunctive treatment of major depressive disorder in patients with an inadequate response to standard antidepressant therapies.

Key Facts Surrounding This News Item

  • ALKS had a POWR Rating of D (Sell) coming into today.
  • ALKS was -1.58% below its 10-Day Moving Average coming into today.
  • ALKS was -17.34% below its 20-Day Moving Average coming into today.
  • ALKS was -24.05% below its 50-Day Moving Average coming into today.
  • ALKS was -22.88% below its 100-Day Moving Average coming into today.
  • ALKS was -20.94% below its 200-Day Moving Average coming into today.
  • ALKS had returned -22.29% year-to-date leading up to today’s news, versus a -0.24% return from the benchmark S&P 500 during the same period.

More Info About Alkermes plc – Ordinary Shares (ALKS)

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. The company was founded in 1987 and is based in Dublin, Ireland. View our full ALKS ticker page with ratings, news, and more.

Try Premium Today!

Get access to our daily newsletters, Best Stocks List, POWR Ratings, and much more!
Free for 14 days -- no credit card required!

Sign Up Now

ALKS at a Glance

ALKS Current POWR Rating™
Overall POWR Rating™
ALKS Current Price $41.56 1.09%
More ALKS Ratings, Data, and News

ALKS Price Reaction

The day of this event (Apr. 16, 2018)
ALKS Closing Price$44.43 4.47%
ALKS Volume6,109,200
561.98% from avg
Leading up to this event
ALKS 1-mo return30.56%
After this event
ALKS 1-day return8.26%
ALKS 3-day return7.84%
ALKS 5-day return5.87%

ALKS Price Chart

More Alkermes plc - Ordinary Shares (ALKS) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ALKS News
Page generated in 1.0354 seconds.